ZTS (NYSE) - Zoetis Inc
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US98978V1035
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Web URL:
Classification
Market Cap in USD | 87,658m |
Sector | Healthcare |
Industry | Drug Manufacturers-Specialty & Generic |
GiC SubIndustry | Pharmaceuticals |
TER | 0.00% |
IPO / Inception | 2013-02-01 |
Ratings
Fundamental | 6.91 |
Dividend | 7.74 |
Performance 5y | 6.40 |
Rel. Performance vs Sector | 0.49 |
Analysts | 4.31 |
Fair Price Total Ret. | 177.21 |
Fair Price DCF | todo |
Technical
Growth TTM | 19.49% |
CAGR 5y | 15.08% |
CAGR / Mean Drawdown 5y | 1.15 |
Sharpe Ratio TTM | 0.48 |
Alpha vs SP500 TTM | 0.19 |
Beta vs SP500 5y weekly | 1.00 |
CAPM | 7.50% |
Average Daily Range 2m | 2.06% |
Reversal Oscillator | 9.45 |
Volatility GJR Garch 1y | 24.80% |
Price / SMA 50 | -3.49% |
Price / SMA 200 | 4.42% |
Current Volume | 1550.7k |
Average Volume 20d | 1650.7k |
Dividends
Yield TTM | 0.82% |
Yield on Cost 5y | 1.64% |
Dividends CAGR 5y | 20.87% |
Consistency of Dividends all time | 100.0% |